How Policy Shapes the Future of Life Sciences

In this New Year episode of the Making Medicine Podcast, we revisit a full-length conversation with U.S. Senator Thom Tillis of North Carolina, focused on the policies shaping US life sciences. The discussion explores intellectual property, drug pricing dynamics, regulatory balance, and how innovation ecosystems grow at the state and national level. The episode examines approaches to sustaining research and development while maintaining global competitiveness. It also considers the long-term implications of regulatory uncertainty and international competition.Which policy issue do you think most impacts biotech innovation today?How should decision-makers balance affordability and long-term R&D investment?What does the US need to maintain leadership in life sciences?If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more: https://x.com/MakingMedPod https://www.instagram.com/makingmedicinepod/ https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=trueTimestamps:0:00 Episode disclaimer 0:17 Welcome to Making Medicine and episode overview0:30 Why this conversation matters for 20261:24 Introducing Senator Thom Tillis2:16 Building a life sciences ecosystem in North Carolina3:43 Economic impact of biotech investment4:27 Tax and regulatory strategy for innovation7:52 Balancing reform and economic stability9:58 Why intellectual property matters for life sciences 12:18 Government involvement and innovation risks13:51 Drug pricing policy and unintended consequences17:05 R&D investment impacts and innovation trade-offs20:26 Global competition and China’s growing role22:55 Changing the narrative around life sciences26:52 What’s next after public service28:58 Closing reflections and future outlookDISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.